You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》SPAC Vivere Lifesciences申請在港上市 天境生物(IMAB.US)為發起人
阿思達克 02-23 10:24
特殊目的收購公司(SPAC) Vivere Lifesciences Acquisition Corp. 向聯交所提交上市申請,獨家保薦人為瑞銀。 初步招股文件顯示,Vivere Lifesciences發起人為鼎珮資產管理、天境生物(IMAB.US),以及董事發起人鼎珮集團董事總經理伍兆威、天境生物首席戰略官朱杰倫及鼎珮集團私募權團隊副總裁陳雅均,三者分別持有公司B 類股份的52%、30%及18%。 公司計劃將聚焦於中國或其他具有中國視角的全球醫療健康行業的公司,尤其專注於從事生物科技、診斷、醫療專業設備、新型平台技術及醫療健康相關科技、合成生物學以及CXO等領域。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account